Romania Cătălin Vicol introduces Biofarm, a leading Romanian pharma producer on the verge of significant international expansion. Vicol shares his insights on the potential of the Romanian consumer healthcare (CHC) market, which accounts for 95 percent of Biofarm’s activities, and discloses his ambition of becoming the number one CHC pharmaceutical producer…
Italy Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based subsidiary focusing on rare and ultra-rare diseases. We are very excited to put Chiesi’s decades of experience in drug development and dedication to patients to work to make a positive difference…
India Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an expansion into the Australia and New Zealand markets. We see ourselves as a company that has great capabilities and is investing big time…
Hungary As the only one of Hungary’s four historical pharmaceutical manufactures to have resisted international acquisition, Gedeon Richter stands alone as the country’s national champion. However, the company does not exist in a vacuum and, like many globally active mid-cap pharma players, establishing partnerships across the entire value chain has been…
China Mike Chen, president and CEO of ACROBiosystems, shares his global success as a manufacturer of recombinant proteins supporting biologics R&D and how he hopes to expand his business to eventually set up a multifaceted platform for MNCs and biotechs. By having a manufacturing facility in the USA or Europe,…
Hungary Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its exciting new collaboration with Allergan in the US market, and the landmark launch of Gedeon’s first company-developed biosimilar in Japan. Our advancement in biotechnology has been a key development for Gedeon Richter this year…
Taiwan While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market, rising medical needs in Asia are helping foster more regionally-focused strategies. According to data from the World Bank, healthcare spending in Asia is expected to grow at a CAGR of 9.2…
UAE LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with Canada’s Apotex to produce 120 million generic tablets and medicines for Motor Neurone Disease annually over the next 10 years. This partnership is an important milestone, not only for LIFEPharma and…
Thailand Suthep Namwongsamran, GM of M&H Manufacturing, provides insights into the distinctive model that has allowed M&H to become one of Thailand’s leading domestic pharmaceutical manufacturers. He also outlines the expected development of the M&H’s international strategy and his focus on bringing biosimilars to Thailand via mutually beneficial partnerships. We…
Sweden SwedenBIO gathers together actors from across the life science ecosystem of Sweden, with members ranging from small university spin-offs to large international companies, incubators, science parks, patent bureaus, and funding bodies. Jonas Ekstrand and Helena Strigård outline what makes Sweden such an innovation powerhouse, how SwedenBIO has fostered international connections,…
Sweden Sweden’s pharmaceutical exports shot up 27% in first quarter 2019, continuing an upward growth trend in an industry that is increasingly well-renowned internationally for its quality and high technology. The Swedish healthcare and life sciences sector enjoys a good reputation abroad and is strongly associated with quality and innovation…
Sweden Swecare Foundation is a platform where academia, public sector actors, and the private sector come together to promote the internationalization and export growth of Swedish healthcare and life sciences. Anna Riby, regional director East Asia, Shampa Bari, regional director South Asia and Cécilia Wismar, office manager/CEO assistant, explain how the…
See our Cookie Privacy Policy Here